| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Revolution Medicines, Inc. | Director | Common Stock | 96.6K | $3.84M | $39.80 | Jun 26, 2025 | Direct |
| GILEAD SCIENCES, INC. | Director | Non-qualified Stock Option (Right to Buy) | 12.6K | $1M | $79.45 | May 8, 2024 | Direct |
| GILEAD SCIENCES, INC. | Director | Common Stock | 5.15K | $533K | $103.63 | May 7, 2025 | Direct |
| GILEAD SCIENCES, INC. | Director | Restricted Stock Unit | 7.8K | $509K | $65.27 | May 8, 2024 | Direct |
| Moderna, Inc. | Director | Restricted Stock Units | 16.2K | $111K | $113.40 | Apr 30, 2025 | Direct |
| Moderna, Inc. | Director | Common Stock | 2.35K | $62.7K | $26.67 | Apr 30, 2025 | Direct |
| Olema Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 24.2K | Jun 11, 2025 | Direct | ||
| Revolution Medicines, Inc. | Director | Stock Option (Right to Buy) | 11.6K | Jun 26, 2025 | Direct | ||
| GILEAD SCIENCES, INC. | Director | Non-qualified Stock Option (Right to Buy) | 6.81K | May 7, 2025 | Direct | ||
| Moderna, Inc. | Director | Stock Option (Right to Buy) | 5.67K | May 6, 2024 | Direct | ||
| EQRx, Inc. | Director | Common Stock | 0 | $2.21 | Nov 9, 2023 | Direct | |
| EQRx, Inc. | Director | Earn-out Shares | 0 | Nov 9, 2023 | Direct | ||
| EQRx, Inc. | Director | Stock Option (Right to Buy) | 0 | Nov 9, 2023 | Direct |